Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

OrbiMed Raises $3.5 Billion Across Three Funds

Posted in Life Sciences Investing

OrbiMed has announced it has raised $3.5 billion in commitments for its latest private investment funds.

The investments are broken down as follows:

  • $1.5 billion for OrbiMed Private Investments VIII, which invests primarily in North America and Europe with a focus on biotechnology, medical device and diagnostics companies
  • $800 million for OrbiMed Asia Partners IV, which invests primarily in China and India with a focus on biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services
  • $1.2 billion for OrbiMed Royalty & Credit Opportunities III, which invests globally with a focus on healthcare companies and institutions

OrbiMed, headquartered in New York, is a life sciences investment firm with about $18 billion in assets under management.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.